PAI Pharma acquires Nivagen to boost US injectable drug production
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
The acquisition marks a major step in PAI’s strategy to expand domestic pharmaceutical manufacturing
Ultra-high purity surfactant for biologics and parenteral drug formulations
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
The new plant will manufacture high-quality Type I borosilicate glass tubing
Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
Subscribe To Our Newsletter & Stay Updated